Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis

scientific article published on 24 October 2007

Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JNS.2007.09.038
P698PubMed publication ID17961597

P2093author name stringChigumi Ohtsuka
Yasuo Terayama
Takahiko Murata
P433issue1-2
P921main subjectamyotrophic lateral sclerosisQ206901
P1104number of pages4
P304page(s)66-69
P577publication date2007-10-24
P1433published inJournal of the Neurological SciencesQ6296168
P1476titleIncreased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis
P478volume267

Reverse relations

cites work (P2860)
Q34920387A mouse model of familial ALS has increased CNS levels of endogenous ubiquinol9/10 and does not benefit from exogenous administration of ubiquinol10
Q34610044A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
Q50090464Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System
Q28392768Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
Q33467388Fine mapping of gene regions regulating neurodegeneration
Q39280494Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy
Q37073851Nutrition and dietary supplements in motor neuron disease
Q99555756PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction
Q30494108Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Q38776278Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Q34808701The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type.
Q93014731Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review

Search more.